Akute Bronchitis Mit - Causes of Bronchitis and Ayurvedic Home Remedies
Bronchitis - causes and Ayurvedic home remedies for bronchitis. Bronchitis is inflammation of bronchi or air passages that carry air to lungs. People suffering from bronchitis see a heightening of this disease in damp climate.
Thus treating bronchitis primarily aims at treating abnormalities in digestive system. The medicines also have curative powers to treat lung diseases. There is a vast ocean of knowledge connected with Herbal Remedies Bronchitis. What is included here can be considered a fraction of this knowledge!
Ayurveda,
bronchitis drug treatment as kasa roga (casa roga). According to Ayurveda concepts, germs cause this disease. However, accumulation of phlegm in the digestive tract after indigestion is the primary reason for bronchitis. There are many varieties of Treating Bronchitis found today. However, we have stuck to the description of only one variety to prevent confusion!
Herbal Remedies for Bronchitis
Tulsi (Holy Basil Ocimum sanctum), adathoda (Adathoda vasika), linseed, etc are used in the treatment of bronchitis. Treating Bronchitis are versatile as they are found in all parts and walks of life. It all depends on the way you take it
Precautionary measures include avoiding exposure to humidity, dust and other allergens. You should also take care of your food and diet. Include a lot of fresh fruits and vegetables in your daily diet. Avoid smoking, alcohol and other addictives. Canned foods items are also best avoided. Easy to digest food items should form the main meals. Eat lots of fibrous food items and avoid the chances of constipation. Problems in digestion are the beginning point of bronchitis and you need to take extreme care in ensuring you have smooth digestion.
About the Author:
Dev Sri provides insider information about Ayurvedic herbal medicine practices and Ayurveda in Kerala.
Wild oregano oil Ayurvedic medicines at *****
- Order to properly treat a cough, one must first determine the root cause of his cough.
- Most often, a person will experience significant coughing when experiencing the common cold, the flu, or bronchitis.
Bronchitis is a condition that exists when an inflammation of the bronchial tubes, which are the main air passages that bring air to the lung tissue, exists. When these passages become aggravated they produce mucous, which in turn stimulates coughing in an effort to clear the passages. Ignorance is bliss they say. However, do you find this practical when you read so much about Bronchitis Condition?
Addition, one should be aware of whether or not the phlegm is green or yellow in color, which may be indicative of a bacterial infection, in which case one should speak with his physician. If blood appears in the mucous that is coughed up, medical attention should be sought immediately as there may be a serious underlying condition causing the cough. Also, if you experience a shortness of breath or difficulty breathing, seek immediate medical attention. Make the best use of life by learning and reading as much as possible. read about things unknown, and more about things known, like about Bronchitis Cough.
Bronchitis associated with cigarette smoking will only go away after the smoking has stopped. Even though coughing may become uncomfortable at times, keep in mind it is your body's way of trying to heal by ridding itself of the excess mucous in your chest. Being aware of what is causing your cough will allow you to take the proper course of treatment and hopefully shorten the duration of your cough. I have found an effective natural cough remedy that works to fight coughs caused by the common cold, the flu and bronchitis. life is short. Use it to its maximum by utilizing whatever knowledge it offers for knowledge is important for all walks of life. Even the crooks have to be intelligent!
Sana'a Baba is the owner of ***** as well as a practicing attorney. As an attorney, I've learned the importance of asking questions and getting as much of the facts as possible. This practice definitely is important when it comes to our bodies and health. When a person is empowered by having knowledge about what is going on with one's body, he/she is more likely to take an active role in seeking the proper treatment when he has an ailment. I have always been a self advocate of trying natural remedies before immediately turning to over- used conventional medicine. For information about getting rid of a cough with a natural remedy visit ***** to see what tested and tried natural cough remedy has worked for others.
Cough can be Considered Wet/Chesty or Dry
Many times a cough starts out as being dry and then progresses to being considered a wet/chesty cough. A dry cough is mostly considered a bothersome nuisance. It has no real purpose in helping to rid the body of anything. Whenever one reads any reading matter, it is vital that the person enjoys reading it. One should grasp the meaning of the matter, only then can it be considered that the reading is complete.
Wet cough can be beneficial in aiding the body to expel phlegm from the chest. A wet/ chesty cough can be categorized as being productive or non-productive. Wet coughs are considered to be productive when mucous is being moved from the chest. A cough is considered to be non-productive when mucous is not being expelled from the chest regardless of the coughing. Accept the way things are in life. Only then will you be able to accept these points on Bronchitis Condition. Bronchitis Condition can be considered to be part and parcel of life.
The fluoroquinolones are a relatively new group of antibiotics. Fluoroquinolones were first introduced in 1986, but they are really modified quinolones, a class of antibiotics, whose accidental discovery occurred in the early 1960.
Third Generation
The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species. Ignorance is bliss, is it? Isn't it better to learn more than not to know about something like Bronchitis. So we have produced this article so that you can learn more about it!
Second Generation
The second-generation fluoroquinolones have increased gram-negative activity, as well as some gram-positive and atypical pathogen coverage. Compared with first-generation quinolones, these drugs have broader clinical applications in the treatment of complicated urinary tract infections and pyelonephritis, sexually transmitted diseases, selected pneumonias and skin infections. A rolling stone gathers no moss. So if I just go on writing, and you don't understand, then it is of no use of me writing about Chronic Bronchitis! Whatever written should be understandable by the reader.
Fluoroquinolones disadvantages: Tendonitis or tendon rupture Multiple drug interactions Not used in children Newer quinolones produce additional toxicities to the heart that were not found with the older agents Classification of Fluoroquinolones
As a group, the fluoroquinolones have excellent in vitro activity against a wide range of both gram-positive and gram-negative bacteria. The newest fluoroquinolones have enhanced activity against gram-positive bacteria with only a minimal decrease in activity against gram-negative bacteria. Their expanded gram-positive activity is especially important because it includes significant activity against Streptococcus pneumoniae.
Fluoroquinolones Advantages:
Ease of administration Daily or twice daily dosing Excellent oral absorption Excellent tissue penetration Prolonged half-lives Significant entry into phagocytic cells Efficacy Overall safety It is with much interest that we got about to write on Chronic Bronchitis. So we do hope that you too read this article with the same, if not more interest!
Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin. Writing is something that has to be done when one is in the mood to write. So when we got in the mood to write about Bronchitis, nothing could stop us from writing!
Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days. We were actually wondering how to get about to writing about Chronic Bronchitis. However once we started writing, the words just seemed to flow continuously!
.
Gastrointestinal Effects
The most common adverse events experienced with fluoroquinolone administration are gastrointestinal (nausea, vomiting, diarrhea, constipation, and abdominal pain), which occur in 1 to 5% of patients. CNS effects. Headache, dizziness, and drowsiness have been reported with all fluoroquinolones. Insomnia was reported in 3-7% of patients with ofloxacin. Severe CNS effects, including seizures, have been reported in patients receiving trovafloxacin. Seizures may develop within 3 to 4 days of therapy but resolve with drug discontinuation. Although seizures are infrequent, fluoroquinolones should be avoided in patients with a history of convulsion, cerebral trauma, or anoxia. No seizures have been reported with levofloxacin, moxifloxacin, gatifloxacin, and gemifloxacin. With the older non-fluorinated quinolones neurotoxic symptoms such as dizziness occurred in about 50% of the patients. Phototoxicity. Exposure to ultraviolet A rays from direct or indirect sunlight should be avoided during treatment and several days (5 days with sparfloxacin) after the use of the drug. The degree of phototoxic potential of fluoroquinolones is as follows: lomefloxacin > sparfloxacin > ciprofloxacin > norfloxacin = ofloxacin = levofloxacin = gatifloxacin = moxifloxacin. Musculoskeletal effects. Concern about the development of musculoskeletal effects, evident in animal studies, has led to the contraindication of fluoroquinolones for routine use in children and in women who are pregnant or lactating. Tendon damage (tendinitis and tendon rupture). Although fluoroquinolone-related tendinitis generally resolves within one week of discontinuation of therapy, spontaneous ruptures have been reported as long as nine months after cessation of fluoroquinolone use. Potential risk factors for tendinopathy include age >50 years, male gender, and concomitant use of corticosteroids. Hepatoxicity. Trovafloxacin use has been associated with rare liver damage, which prompted the withdrawal of the oral preparations from the U.S. market. However, the IV preparation is still available for treatment of infections so serious that the benefits outweigh the risks. Cardiovascular effects. The newer quinolones have been found to produce additional toxicities to the heart that were not found with the older compounds. Evidence suggests that sparfloxacin and grepafloxacin may have the most cardiotoxic potential. Hypoglycemia/Hyperglycemia. Recently, rare cases of hypoglycemia have been reported with gatifloxacin and ciprofloxacin in patients also receiving oral diabetic medications, primarily sulfonylureas. Although hypoglycemia has been reported with other fluoroquinolones (levofloxacin and moxifloxacin), the effects have been mild. Hypersensitivity. Hypersensitivity reactions occur only occasionally during quinolone therapy and are generally mild to moderate in severity, and usually resolve after treatment is stopped.
Side Effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects. It is rather inviting to go on writing on Chronic Bronchitis. however as there is a limitation to the number of words to be written, we have confined ourselves to this. However, do enjoy yourself reading it.
Fourth Generation
The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. Do not judge a book by its cover; so don't just scan through this matter on Bronchitis. read it thoroughly to judge its value and importance.
Conditions treated with Fluoroquinolones: indications and uses The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. The serum elimination half-life of the fluoroquinolones range from 3 -20 hours, allowing for once or twice daily dosing. Isn't it amazing how much information can be transferred through a single page? So much stands to gain, and to lose about Chronic Bronchitis through a single page.
Urinary tract infections (norfloxacin, lomefloxacin, enoxacin, ofloxacin, ciprofloxacin, levofloxacin, gatifloxacin, trovafloxacin) Lower respiratory tract infections (lomefloxacin, ofloxacin, ciprofloxacin, trovafloxacin) Skin and skin-structure infections (ofloxacin, ciprofloxacin, levofloxacin, trovafloxacin) Urethral and cervical gonococcal infections (norfloxacin, enoxacin, ofloxacin, ciprofloxacin, gatifloxacin, trovafloxacin) Prostatitis (norfloxacin, ofloxacin, trovafloxacin) Acute sinusitis (ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin (Avelox), trovafloxacin) Acute exacerbations of chronic bronchitis (levofloxacin, sparfloxacin (Zagam), gatifloxacin, moxifloxacin, trovafloxacin) Community-acquired pneumonia (levofloxacin, sparfloxacin, gatifloxacin, moxifloxacin, trovafloxacin) It is rather interesting to note that people like reading about Bronchitis if they are presented in an easy and clear way. The presentation of an article too is important for one to entice people to read it!
.
All of the fluoroquinolones are effective in treating urinary tract infections caused by susceptible organisms. They are the first-line treatment of acute uncomplicated cystitis in patients who cannot tolerate sulfonamides or TMP, who live in geographic areas with known resistance > 10% to 20% to TMP-SMX, or who have risk factors for such resistance.
First Generation
The first-generation agents include cinoxacin and nalidixic acid, which are the oldest and least often used quinolones. These drugs had poor systemic distribution and limited activity and were used primarily for gram-negative urinary tract infections. Cinoxacin and nalidixic acid require more frequent dosing than the newer quinolones, and they are more susceptible to the development of bacterial resistance.
The fluoroquinolones are a family of synthetic, broad-spectrum antibacterial agents with bactericidal activity. The parent of the group is nalidixic acid, discovered in 1962 by Lescher and colleagues. The first fluoroquinolones were widely used because they were the only orally administered agents available for the treatment of serious infections caused by gram-negative organisms, including Pseudomonas species. It is always better to have compositions with as little corrections in it as possible. This is why we have written this composition on Bronchitis with no corrections for the reader to be more interested in reading it.
Fluoroquinolones are approved for use only in people older than 18. They can affect the growth of bones, teeth, and cartilage in a child or fetus. The FDA has assigned fluoroquinolones to pregnancy risk category C, indicating that these drugs have the potential to cause teratogenic or embryocidal effects. Giving fluoroquinolones during pregnancy is not recommended unless the benefits justify the potential risks to the fetus. These agents are also excreted in breast milk and should be avoided during breast-feeding if at all possible.
Home
Search
Login
Register